chr2-214792281-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBS2_Supporting

The NM_000465.4(BARD1):​c.364+16A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,611,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

BARD1
NM_000465.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.48

Publications

0 publications found
Variant links:
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-214792281-T-C is Benign according to our data. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214792281-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 372040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BARD1NM_000465.4 linkc.364+16A>G intron_variant Intron 3 of 10 ENST00000260947.9 NP_000456.2 Q99728-1A0AVN2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BARD1ENST00000260947.9 linkc.364+16A>G intron_variant Intron 3 of 10 1 NM_000465.4 ENSP00000260947.4 Q99728-1

Frequencies

GnomAD3 genomes
AF:
0.0000330
AC:
5
AN:
151640
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000279
AC:
7
AN:
250530
AF XY:
0.0000369
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000530
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000199
AC:
29
AN:
1460104
Hom.:
0
Cov.:
32
AF XY:
0.0000207
AC XY:
15
AN XY:
726358
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33398
American (AMR)
AF:
0.00
AC:
0
AN:
44546
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39648
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86160
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53320
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.0000234
AC:
26
AN:
1110902
Other (OTH)
AF:
0.0000332
AC:
2
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000330
AC:
5
AN:
151640
Hom.:
0
Cov.:
30
AF XY:
0.0000270
AC XY:
2
AN XY:
74040
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41274
American (AMR)
AF:
0.00
AC:
0
AN:
15206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10478
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000589
AC:
4
AN:
67924
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000189
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial cancer of breast Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 24, 2016
Counsyl
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

not provided Benign:1
Jun 17, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Jun 15, 2015
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.28
DANN
Benign
0.67
PhyloP100
-1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201219625; hg19: chr2-215657005; API